Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded
Renée A. Douma(Amsterdam UMC Location University of Amsterdam), Marc Righini(University Hospital of Geneva), Shannon M. Bates(McMaster University), Grégoire Le Gal(University of Ottawa), Marc Carrier(University of Ottawa), Roger E. G. Schutgens(University Medical Center Utrecht), Arnaud Perrier(University of Geneva), H Bounameaux(Service de la Santé Publique), Douwe H. Biesma(Unknown), Pieter W. Kamphuisen(University Medical Center Groningen), Cristina Legnani(University of Bologna), Jeffrey S. Ginsberg(Thrombosis and Atherosclerosis Research Institute), Gualtiero Palareti(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Minkang Tan(Leiden University Medical Center), Gerben C. Mol(Diakonessenhuis hospital)
Cited by 130
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Diagnosis of DVT
|CHEST Journal|2012|676
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589